(18)F-C2Am: a targeted imaging agent for detecting tumor cell death in vivo using positron emission tomography

INTRODUCTION: Trialing novel cancer therapies in the clinic would benefit from imaging agents that can detect early evidence of treatment response. The timing, extent and distribution of cell death in tumors following treatment can give an indication of outcome. We describe here an (18)F-labeled der...

Descripción completa

Detalles Bibliográficos
Autores principales: Bulat, Flaviu, Hesse, Friederike, Hu, De-En, Ros, Susana, Willminton-Holmes, Connor, Xie, Bangwen, Attili, Bala, Soloviev, Dmitry, Aigbirhio, Franklin, Leeper, Finian. J., Brindle, Kevin M., Neves, André A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726082/
https://www.ncbi.nlm.nih.gov/pubmed/33296043
http://dx.doi.org/10.1186/s13550-020-00738-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726082/
https://www.ncbi.nlm.nih.gov/pubmed/33296043
http://dx.doi.org/10.1186/s13550-020-00738-7

Ejemplares similares